RééDOC
75 Boulevard Lobau
54042 NANCY cedex

Christelle Grandidier Documentaliste
03 83 52 67 64


F Nous contacter

0

Article

--";3! O

F x |

     

-A +A

Botulinum toxin type A or selective neurotomy for treating focal spastic muscle overactivity ?

DELTOMBE T; LEJEUNE T; GUSTIN T
ANN PHYS REHABIL MED , 2019, vol. 62, n° 4, p. 220-224
Doc n°: 190294
Localisation : Documentation IRR

D.O.I. : https://doi.org/10.1016/j.rehab.2018.07.008
Descripteurs : AD32 - SPASTICITE, AF211 - HEMIPLEGIE

Conclusion

Botulinum toxin type A has the highest level of evidence and the largest range of indications. However, the botulinum toxin effect is reversible and seems less effective, which supports a permanent surgical treatment such as selective neurotomy, especially for the spastic foot. Further research is needed to compare the effect of botulinum toxin type A and selective neurotomy for the different types of spastic muscle overactivity and clinical patterns.

Hemiplegia, Muscle spasticity, Motor nerve block, Neurotomy, Equinovarus foot, toxine botulique, spasticité

Langue : ANGLAIS

|

Ajouter au panier

4

Gerer mes paniers

|

Signaler une erreur

Mes paniers

4

Gerer mes paniers

0